Thromboembolism peaking 3 months after starting testosterone therapy: testosterone–thrombophilia interactions

No abstract is available for this paper.

• Publication year

  2017

• Venue

  Journal of Investigative Medicine

• Publication date

  2017-12-15

• Fields of study

  Medicine

• Identifiers
  DOI 10.1136/jim-2017-000637PMID 29248890
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Effects of Testosterone Treatment in Older Men.

  2018cited by this paper
• Testosterone Treatment and Cognitive Function in Older Men With Low Testosterone and Age-Associated Memory Impairment

  2017cited by this paper
• Association of Testosterone Levels With Anemia in Older Men: A Controlled Clinical Trial

  2017cited by this paper
• Effect of Testosterone Treatment on Volumetric Bone Density and Strength in Older Men With Low Testosterone: A Controlled Clinical Trial

  2017cited by this paper
• Testosterone Treatment and Coronary Artery Plaque Volume in Older Men With Low Testosterone

  2017cited by this paper
• Testosterone treatment and cardiovascular and venous thromboembolism risk: what is ‘new’?

  2017cited by this paper
• Thrombophilia in Klinefelter Syndrome With Deep Venous Thrombosis, Pulmonary Embolism, and Mesenteric Artery Thrombosis on Testosterone Therapy: A Pilot Study

  2017cited by this paper
• The cost of seeking an edge: Recurrent renal infarction in setting of recreational use of anabolic steroids

  2017cited by this paper
• Association between Use of Exogenous Testosterone Therapy and Risk of Venous Thrombotic Events among Exogenous Testosterone Treated and Untreated Men with Hypogonadism.

  2016cited by this paper
• Could Testosterone Replacement Therapy in Hypogonadal Men Ameliorate Anemia, a Cardiovascular Risk Factor? An Observational, 54-Week Cumulative Registry Study.

  2016cited by this paper
• Effects of Testosterone Treatment in Older Men.

  2016cited by this paper
• Inherited antithrombin deficiency and anabolic steroids: a risky combination.

  2016cited by this paper
• Four Thrombotic Events Over 5 Years, Two Pulmonary Emboli and Two Deep Venous Thrombosis, When Testosterone-HCG Therapy Was Continued Despite Concurrent Anticoagulation in a 55-Year-Old Man With Lupus Anticoagulant

  2016cited by this paper
• Testosterone treatment and risk of venous thromboembolism: population based case-control study

  2016cited by this paper
• Guidance for the evaluation and treatment of hereditary and acquired thrombophilia

  2016cited by this paper
• Successful penile reconstruction following prior arteriovenous loop thrombosis due to undiagnosed protein-S deficiency and exogenous testosterone

  2016cited by this paper
• Venous thromboembolism and subsequent permanent work‐related disability

  2016cited by this paper
• Thrombophilia in 67 Patients With Thrombotic Events After Starting Testosterone Therapy

  2016cited by this paper
• Association Between Testosterone Replacement Therapy and the Incidence of DVT and Pulmonary Embolism: A Retrospective Cohort Study of the Veterans Administration Database.

  2016cited by this paper
• Association between exogenous testosterone and cardiovascular events: an overview of systematic reviews.

  2016cited by this paper
• Endocrine Society of Australia position statement on male hypogonadism (part 1): assessment and indications for testosterone therapy

  2016cited by this paper
• Association Between Testosterone Supplementation Therapy and Thrombotic Events in Elderly Men.

  2015cited by this paper
• Testosterone and "Age-Related Hypogonadism"--FDA Concerns.

  2015cited by this paper
• Testosterone, thrombophilia, thrombosis.

  2015cited by this paper
• Re: Testosterone Products: Drug Safety Communication - FDA Cautions about Using Testosterone Products for Low Testosterone due to Aging; Requires Labeling Change to Inform of Possible Increased Risk of Heart Attack and Stroke.

  2015cited by this paper
• European Union-28: An annualised cost-of-illness model for venous thromboembolism

  2015cited by this paper
• High Estrogen in Men After Injectable Testosterone Therapy

  2015cited by this paper
• Risk of Venous Thromboembolism in Men Receiving Testosterone Therapy.

  2015cited by this paper
• Testosterone Therapy, Thrombophilia–Hypofibrinolysis, and Hospitalization for Deep Venous Thrombosis-Pulmonary Embolus

  2014cited by this paper
• Increased Risk of Non-Fatal Myocardial Infarction Following Testosterone Therapy Prescription in Men

  2014cited by this paper
• 30-Year Mortality After Venous Thromboembolism: A Population-Based Cohort Study

  2014cited by this paper
• Testosterone, thrombophilia, thrombosis

  2014cited by this paper
• Testosterone, Thrombophilia, and Thrombosis

  2014cited by this paper
• An update on male hypogonadism therapy

  2014cited by this paper
• Testosterone therapy, thrombosis, thrombophilia, cardiovascular events.

  2014cited by this paper
• Testosterone, anastrozole, factor V Leiden heterozygosity and osteonecrosis of the jaws

  2014cited by this paper
• Association of testosterone therapy with mortality, myocardial infarction, and stroke in men with low testosterone levels.

  2013cited by this paper
• The ASH Choosing Wisely®campaign: five hematologic tests and treatments to question.

  2013cited by this paper
• Beneficial and adverse effects of testosterone on the cardiovascular system in men.

  2013cited by this paper
• An update on menopausal hormone replacement therapy in women and cardiovascular disease

  2013cited by this paper
• Thrombosis in Three Postmenopausal Women Receiving Testosterone Therapy for Low Libido

  2013cited by this paper
• Testosterone therapy and cardiovascular events among men: a systematic review and meta-analysis of placebo-controlled randomized trials

  2013cited by this paper
• The Role of the Factor V Leiden Mutation in Osteonecrosis of the Hip

  2013cited by this paper
• The ASH Choosing Wisely® campaign: five hematologic tests and treatments to question.

  2013cited by this paper
• The Effect of Prothrombotic Blood Abnormalities on Risk of Deep Vein Thrombosis in Users of Hormone Replacement Therapy

  2011cited by this paper
• A Randomized Controlled Trial of Whole Body Vibration Exposure on Markers of Bone Turnover in Postmenopausal Women

  2011cited by this paper
• Thrombotic events after starting exogenous testosterone in men with previously undiagnosed familial thrombophilia.

  2011cited by this paper
• Testosterone and the Male Skeleton: A Dual Mode of Action

  2011cited by this paper
• Clinical review 1: Adverse effects of testosterone therapy in adult men: a systematic review and meta-analysis.

  2010cited by this paper
• Adverse events associated with testosterone administration.

  2010cited by this paper
• Testosterone therapy in men with androgen deficiency syndromes: an Endocrine Society clinical practice guideline.

  2010cited by this paper
• Incidence of venous thromboembolism in contraceptive users

  2010cited by this paper
• Thrombophilia, hypofibrinolysis, the eNOS T-786C polymorphism, and multifocal osteonecrosis.

  2008cited by this paper
• Heritable Thrombophilia-Hypofibrinolysis and Osteonecrosis of the Femoral Head

  2008cited by this paper
• Hormone replacement therapy and risk of venous thromboembolism in postmenopausal women: systematic review and meta-analysis

  2008cited by this paper
• A systematic review of the clinical effectiveness and cost-effectiveness of enzyme replacement therapies for Fabry's disease and mucopolysaccharidosis type 1.

  2006cited by this paper
• Screening for thrombophilia in high-risk situations: systematic review and cost-effectiveness analysis. The Thrombosis: Risk and Economic Assessment of Thrombophilia Screening (TREATS) study.

  2006cited by this paper
• Screening for thrombophilia in high‐risk situations: a meta‐analysis and cost‐effectiveness analysis

  2005cited by this paper
• Enoxaparin Prevents Progression of Stages I and II Osteonecrosis of the Hip

  2005cited by this paper
• Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results From the Women's Health Initiative randomized controlled trial.

  2002cited by this paper
• State-of-the-Art Review: Antiphospholipid Thrombosis Syndromes

  2001cited by this paper
• Value of family history in identifying women at risk of venous thromboembolism during oral contraception: observational study

  2001cited by this paper
• Testing for the antiphospholipid syndrome: importance of IgA anti-beta 2-glycoprotein I

  2000cited by this paper
• First-time use of newer oral contraceptives and the risk of venous thromboembolism.

  1997cited by this paper
• Selective Screening for the Factor V Leiden Mutation: Is it Advisable prior to the Prescription of Oral Contraceptives?

  1997cited by this paper
• Hyperhomocysteinemia as a risk factor for deep-vein thrombosis.

  1996cited by this paper
• Testosterone increases human platelet thromboxane A2 receptor density and aggregation responses.

  1995cited by this paper
• Criteria for the Diagnosis of Lupus Anticoagulants: An Update

  1995cited by this paper
• Principles of nonexperimental assessment of excess risk, with special reference to adverse drug reactions.

  1989cited by this paper
• [Thrombophilia or thrombosis?].

  1987cited by this paper

• Clomiphene-Induced Portal Vein Thrombosis and Superior Mesenteric Venous Thrombosis

  2024cites this paper
• Testosterone Therapy Does Not Affect Coagulation in Male Hypogonadism: A Longitudinal Study Based on Thrombin Generation

  2024cites this paper
• Testosterone treatment and the risk of osteonecrosis: a pharmacovigilance analysis in Vigibase

  2023cites this paper
• Acute Portal and Superior Mesenteric Vein Thrombosis with Topical Testosterone Therapy: An Adverse Drug Event Case Report

  2022cites this paper
• Predictive Factors of Efficacy Maintenance after Testosterone Treatment Cessation

  2019cites this paper
• Re-Examining Genetic Screening and Oral Contraceptives: A Patient-Centered Review

  2019cites this paper
• Testosterone therapy and venous thromboembolism: A systematic review and meta-analysis.

  2018cites this paper
• Testosterone Therapy, Thrombophilia, Venous Thromboembolism, and Thrombotic Events

  2018influential citation